Standardization and Clinical Evaluation of a Real-Time PCR Assay for the Diagnosis of Pneumocystis jirovecii Pneumonia
Authors:
- Adriana Inés ToranzoATAdriana Inés Toranzo
- Norma FernándezNFNorma Fernández
- Agustina ForastieroAFAgustina Forastiero
- Liliana GuelfandLGLiliana Guelfand
- Luciana FaríasLFLuciana Farías
- Claudia FrolaCFClaudia Frola
- Rosana JordánRJRosana Jordán
- Roberto Damian MoyanoRMRoberto Damian Moyano
- Mariana VialeMVMariana Viale
- 4 November 2025
- journal article
- research article
- Published by Springer Nature in Mycopathologia
- Vol. 190 (6) , 1-10
Abstract
Background Pneumocystis jirovecii pneumonia (PjP) is a life-threatening infection in immunocompromised individuals. Its diagnosis remains challenging, especially in microscopy-negative cases. This study aimed to standardize and validate a qPCR assay targeting the mtLSU rRNA gene for detecting P. jirovecii DNA in respiratory samples from patients in Argentina. Materials and Methods The assay was optimized using plasmid dilutions containing the target gene. Analytical specificity was evaluated against 60 fungal, 21 mycobacterial, and 16 bacterial species. Clinical validation included 101 respiratory samples from symptomatic patients and 37 from healthy individuals. An internal positive control (IPC) was included in all reactions to detect inhibitors. Results The qPCR assay showed a detection limit of 8.8 copies/μL and no cross-reactivity. Among microscopy-confirmed cases, 95.5% were qPCR-positive. Notably, 14.9% of microscopy-negative but clinically compatible cases tested positive. ROC analysis yielded an AUC of 0.96, with an optimal Ct cutoff ≤ 36, providing 90.7% sensitivity and 95.8% specificity. No healthy controls tested positive. A “grey zone” (Ct 36–37.8) was observed, requiring clinical correlation. Conclusions This qPCR assay is highly sensitive and specific, offering a valuable diagnostic tool for PjP. Its performance supports implementation in routine diagnostics, especially when microscopy is inconclusive. However, interpretation in the grey zone requires complementary clinical or biomarker data.Keywords
All Related Versions
Funding Information
- FOCANLIS-2015 (NRU 1524)
This publication has 31 references indexed in Scilit:
- Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysisClinical Microbiology and Infection, 2022
- Histoplasma capsulatum and Pneumocystis jirovecii coinfection in hospitalized HIV and non-HIV patients from a tertiary care hospital in MexicoInternational Journal of Infectious Diseases, 2019
- Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkersClinical Microbiology and Infection, 2015
- (1–3)-Beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2013
- Molecular diagnosis and detection of Pneumocystis jirovecii DHPS and DHFR genotypes in respiratory specimens from Colombian patientsDiagnostic Microbiology and Infectious Disease, 2012
- PneumocystisColonization Is Highly Prevalent in the Autopsied Lungs of the General PopulationClinical Infectious Diseases, 2010
- Diagnostic significance of nested polymerase chain reaction for sensitive detection of Pneumocystis jirovecii in respiratory clinical specimensDiagnostic Microbiology and Infectious Disease, 2009
- Pneumocystis Pneumonia: Current Concepts in Pathogenesis, Diagnosis, and TreatmentClinics in Chest Medicine, 2009
- Quantitative TaqMan PCR for detection of Pneumocystis jiroveciJournal of Microbiological Methods, 2005